相关实验视频
Updated: Jul 3, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
858
血小板数升高与医院内出血性中风的死亡率降低有关:多中心回顾性队列研究
Zhenhua Huang1, Chenglin Liu2, Zhanxing Wu1
1Department of Emergency, Shenzhen Second People's Hospital and The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
Scientific reports
|February 15, 2024
概括
血小板计数 (PC) 影响出血性中风 (HS) 患者的存活率. 高于194×10^9/L的PC与死亡率的降低有关,这表明一个潜在的干预点.
科学领域:
- 神经学 神经学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 出血性中风 (HS) 带来了显著的死亡风险.
- 血小板计数 (PC) 在HS患者,特别是重症监护室 (ICU) 患者的预后作用需要进一步阐明.
研究的目的:
- 调查血小板计数 (PC) 与患有出血性中风 (HS) 患者的死亡率之间的关系.
- 确定PC在预测HS患者死亡率方面的潜在转折点.
主要方法:
- 对3262名HS患者的回顾性分析,这些患者在美国208家医院 (2014-2015年) 住院于重症监护室.
- 采用了多变量逻辑回归和通用添加模型 (GAM) 与平滑的曲线拟合.
- 使用递归算法来确定PC的拐点.
主要成果:
- 发现血小板计数 (PC) 是HS患者死亡率的保护因素 (OR=0.98,P<0.05).
- 确定了PC和HS死亡率之间的非线性关联.
- 确定PC的拐点为194×10^9 / L;每增加PC10个单位,死亡率下降10% PC低于这个值.
结论:
- 在HS患者中存在PC和死亡风险之间的非线性关系.
- 达到194×10^9/L以上的PC水平可能是减少HS患者死亡率的关键干预策略.
相关概念视频
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
523
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K

